Findlay VJ - Search Results

1

AGE metabolites: a biomarker linked to cancer disparity?

Foster D, Spruill L, Walter KR, Nogueira LM, Fedarovich H, Turner RY, Ahmed M, Salley JD, Ford ME, Findlay VJ, Turner DP. Foster D, et al. Among authors: findlay vj. Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):2186-91. doi: 10.1158/1055-9965.EPI-14-0564. Epub 2014 Jul 22. Cancer Epidemiol Biomarkers Prev. 2014. PMID: 25053712 Free PMC article.

2

Defining ETS transcription regulatory networks and their contribution to breast cancer progression.

Turner DP, Findlay VJ, Moussa O, Watson DK. Turner DP, et al. Among authors: findlay vj. J Cell Biochem. 2007 Oct 15;102(3):549-59. doi: 10.1002/jcb.21494. J Cell Biochem. 2007. PMID: 17661355 Review.

3

Global gene expression analysis identifies PDEF transcriptional networks regulating cell migration during cancer progression.

Turner DP, Findlay VJ, Kirven AD, Moussa O, Watson DK. Turner DP, et al. Among authors: findlay vj. Mol Biol Cell. 2008 Sep;19(9):3745-57. doi: 10.1091/mbc.e08-02-0154. Epub 2008 Jun 25. Mol Biol Cell. 2008. PMID: 18579687 Free PMC article.

4

MicroRNA-mediated inhibition of prostate-derived Ets factor messenger RNA translation affects prostate-derived Ets factor regulatory networks in human breast cancer.

Findlay VJ, Turner DP, Moussa O, Watson DK. Findlay VJ, et al. Cancer Res. 2008 Oct 15;68(20):8499-506. doi: 10.1158/0008-5472.CAN-08-0907. Cancer Res. 2008. PMID: 18922924 Free PMC article.

5

Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression.

Turner DP, Findlay VJ, Moussa O, Semenchenko VI, Watson PM, LaRue AC, Desouki MM, Fraig M, Watson DK. Turner DP, et al. Among authors: findlay vj. Prostate. 2011 Dec;71(16):1723-35. doi: 10.1002/pros.21389. Epub 2011 Mar 28. Prostate. 2011. PMID: 21446014 Free PMC article.

6

Slug expression enhances tumor formation in a noninvasive rectal cancer model.

Camp ER, Findlay VJ, Vaena SG, Walsh J, Lewin DN, Turner DP, Watson DK. Camp ER, et al. Among authors: findlay vj. J Surg Res. 2011 Sep;170(1):56-63. doi: 10.1016/j.jss.2011.02.012. Epub 2011 Mar 23. J Surg Res. 2011. PMID: 21470622 Free PMC article.

7

Prostate-Derived ETS Factor Regulates Epithelial-to-Mesenchymal Transition through Both SLUG-Dependent and Independent Mechanisms.

Findlay VJ, Turner DP, Yordy JS, McCarragher B, Shriver MR, Szalai G, Watson PM, Larue AC, Moussa O, Watson DK. Findlay VJ, et al. Genes Cancer. 2011 Feb;2(2):120-9. doi: 10.1177/1947601911410424. Genes Cancer. 2011. PMID: 21779485 Free PMC article.

8

ETS1 transcriptional activity is increased in advanced prostate cancer and promotes the castrate-resistant phenotype.

Smith AM, Findlay VJ, Bandurraga SG, Kistner-Griffin E, Spruill LS, Liu A, Golshayan AR, Turner DP. Smith AM, et al. Among authors: findlay vj. Carcinogenesis. 2012 Mar;33(3):572-80. doi: 10.1093/carcin/bgs007. Epub 2012 Jan 9. Carcinogenesis. 2012. PMID: 22232738

9

Understanding the role of ETS-mediated gene regulation in complex biological processes.

Findlay VJ, LaRue AC, Turner DP, Watson PM, Watson DK. Findlay VJ, et al. Adv Cancer Res. 2013;119:1-61. doi: 10.1016/B978-0-12-407190-2.00001-0. Adv Cancer Res. 2013. PMID: 23870508 Free PMC article. Review.

10

MicroRNA-510 promotes cell and tumor growth by targeting peroxiredoxin1 in breast cancer.

Guo QJ, Mills JN, Bandurraga SG, Nogueira LM, Mason NJ, Camp ER, Larue AC, Turner DP, Findlay VJ. Guo QJ, et al. Among authors: findlay vj. Breast Cancer Res. 2013;15(4):R70. doi: 10.1186/bcr3464. Breast Cancer Res. 2013. PMID: 23971998 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters